Targacept, Inc. to Report Fourth Quarter and 2012 Financial Results on February 13, 2013

Published: Feb 06, 2013

Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that it will report financial results for the fourth quarter and year ended December 31, 2012 on Wednesday, February 13, 2013, after the U.S. financial markets close.

Back to news